⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MNOV News
Medicinova, Inc.
MediciNova to Participate at the 38th Annual ROTH Conference
globenewswire.com
MNOV
MediciNova to Participate at the 38th Annual ROTH Conference
globenewswire.com
MNOV
Form 8-K
sec.gov
MNOV
MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients
globenewswire.com
MNOV
2026 New Year’s Greetings from the CEO
globenewswire.com
MNOV
MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy
globenewswire.com
MNOV
Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throughout Forecast Period (2025-2034) | DelveInsight
prnewswire.com
NRSN
IONQ
MNOV
CLNN
RVSN
BIIB
ABSI
CLNE
MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND
globenewswire.com
MNOV
Message from the CEO to MediciNova Shareholders
globenewswire.com
MNOV
MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor
globenewswire.com
MNOV